The cost-effectiveness of Barrett's surveillance: modelling remains useful
暂无分享，去创建一个
D. Whiteman | L. Gordon | D. Watson | G. Mayne | T. Bright
[1] Jashanpreet Singh,et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis , 2011, Gut.
[2] H. Sørensen,et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.
[3] A. Gavin,et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. , 2011, Journal of the National Cancer Institute.
[4] E. Kuipers,et al. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study , 2010, Gut.